Skip to content

Clinical trials

Phase 2 Non-alcoholic Fatty Liver Disease trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2 Country / region: France Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20083
20123
20141
20152
20162
20173
20182
20195
20203
20216
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated8
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Merck Sharp & Dohme LLC4
Novo Nordisk A/S3
Boehringer Ingelheim2
Inventiva Pharma2
Novartis Pharmaceuticals2
Tobira Therapeutics, Inc.2
Association pour la Recherche sur les Maladies Hépatiques Virales1
Astellas Pharma Inc1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease37
Liver Cirrhosis8
Fibrosis6
Fatty Liver5
Liver Diseases5
Diabetes Mellitus2
Digestive System Diseases2
Obesity2
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.